Injectable Medibots: Programmable DNA could diagnose and treat cancer
Alexandra Goho
Scientists
have created a miniature medical computer out of DNA that can detect
cancer genes in a test tube and respond by releasing a drug. Proving
what had been only a concept, the feat offers a vision of how medicine
might look in the future.
A few years ago, Ehud Shapiro and his colleagues at the
Weizmann Institute of Science in Rehovot, Israel, developed a molecular
computer out of DNA. It was capable of performing simple computations (Math Trek, Science News Online: http://www.sciencenews.org/articles/20020119/mathtrek.asp).
In this biological nanocomputer, strands of DNA serve as software that
control the activity of enzymes. The tiny device is listed in the 2004 Guinness Book of World Records as the smallest biological computing device. Trillions of these DNA-based computers could fit into a single drop of water.
Even so, it takes sophisticated lab equipment to extract results
from the nanocomputers, so they're unlikely to outdo silicon-based
electronic computers, says Shapiro. That's why the Israeli team of
computer scientists and biochemists pursued a different application: a
DNA computer that could by itself diagnose and treat disease.
The researchers programmed their computer for two types of
cancer, prostate cancer and a form of lung cancer. For each cancer, the
team targeted four genes that become either overactive or underactive
in people with the disease. To detect changes in gene activity, the researchers designed
their computer to have three components. The first consists of short
strands of DNA, called transition molecules, that bind to a segment of
the messenger RNA that each cancer gene produces. For their
experiments, the scientists synthesized those segments and put various
amounts of them into test tubes to simulate the presence or absence of
cancer. The second component is a computation module made up of a long
DNA strand. It contains a series of nodes, each of which participates
in a logic operation that determines a diagnosis from the RNA in the
test tube. Each operation relies on a series of reactions in which the
transition molecules direct an enzyme to cut the module in one place or
another. This long DNA strand also harbors the computer's third
component, a therapeutic fragment of DNA that binds to and suppresses
the activity of a disease-causing gene. In a positive diagnosis of malignancy, the computer's
transition molecules detect changes in the activity of all four of a
cancer's genes. When the molecules determine that all four genes have
abnormal activities, the enzyme cuts the computation module so that it
releases the drug. However, even if the activity of only one of the four genes
is normal, the diagnosis is "not cancerous." In these cases, the enzyme
cuts off a different strand of the computer's DNA, which neutralizes
the drug. If the computer releases the drug by accident, a separate
component keeps the system in check by simultaneously releasing the
drug suppressor. The researchers describe their computer in an upcoming Nature.
Ron Weiss, an electrical engineer at Princeton University, rates
the work as "an important feat." He says the research "provides a very
nice way of engineering logic behavior [using DNA]."
So far, the researchers have run the computer only in a test
tube, but they consider that an amazing step forward. An injectable
version would have to work inside cells, and that accomplishment could
take decades. Says Shapiro: "I'm not sure it will be within my
lifetime." Noting people's fears of freewheeling nanoscale robots
circulating in the body, Weiss says, "You have to build safeguards into
these systems. Once researchers are able to design reliable DNA
computers that make a mistake only once every 10 billion times, say,
then I think people will become comfortable with the idea."
| If you have a comment on this article that you would like considered for publication in Science News, send it to editors@sciencenews.org. Please include your name and location.
|
To subscribe to Science News (print), go to https://www.kable.com/pub/scnw/ subServices.asp.
To sign up for the free weekly e-LETTER from Science News, go to http://www.sciencenews.org/pages/subscribe_form.asp.

References: 2004. Biological
computer diagnoses cancer and produces the drug—In a test-tube.
Weizmann Institute press release. April 28. Available at http://www.wisdom.weizmann.ac.il/~udi/PressRoom/new_pages/press_eng.html.
Benenson, Y. . . . and E. Shapiro. In press. An autonomous molecular computer for logical control of gene expression. Nature. Abstract available at http://dx.doi.org/10.1038/nature02551.
Further Readings: Benenson, Y. . . . and E. Shapiro. 2003. DNA molecule provides a computing machine with both data and fuel. Proceedings of the National Acadeny of Sciences 100(March 4):2191-2196. Available at http://www.pnas.org/cgi/content/full/100/5/2191.
______. 2001. Programmable and autonomous computing machine made of biomolecules. Nature 414(Nov. 22):430-434. Abstract available at http://dx.doi.org/10.1038/35106533.
Peterson, I. 2002. Computers by the trillions. Science News Online. (Jan 19). Available at http://www.sciencenews.org/articles/20020119/mathtrek.asp.
Sources: Ehud Shapiro Department of Computer Science and Applied Mathematics Weizmann Institute of Science Rehovot 76100 Israel
Ron Weiss Department of Electrical Engineering B-312, E-Quad Princeton University Princeton, NJ 08544-5263
|